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ABSTRACT
Pathema (http://pathema.jcvi.org) is one of the
eight Bioinformatics Resource Centers (BRCs)
funded by the National Institute of Allergy and
Infectious Disease (NIAID) designed to serve as a
core resource for the bio-defense and infectious
disease research community. Pathema strives to
support basic research and accelerate scientific
progress for understanding, detecting, diagnosing
and treating an established set of six target NIAID
Category A–C pathogens: Category A priority
pathogens; Bacillus anthracis and Clostridium
botulinum, and Category B priority pathogens;
Burkholderia mallei, Burkholderia pseudomallei,
Clostridium perfringens and Entamoeba histolytica.
Each target pathogen is represented in one of four
distinct clade-specific Pathema web resources and
underlying databases developed to target the
specific data and analysis needs of each scientific
community. All publicly available complete genome
projects of phylogenetically related organisms are
also represented, providing a comprehensive col-
lection of organisms for comparative analyses.
Pathema facilitates the scientific exploration of
genomic and related data through its integration
with web-based analysis tools, customized to
obtain, display, and compute results relevant to
ongoing pathogen research. Pathema serves the
bio-defense and infectious disease research
community by disseminating data resulting from
pathogen genome sequencing projects and pro-
viding access to the results of inter-genomic
comparisons for these organisms.
INTRODUCTION
Pathema is a community driven bioinformatics resource
that provides access to genomic data integrated with
analysis tools designed to aid researchers in identifying
potential targets for novel therapeutics, vaccines, and
diagnostics for six selected National Institute of Allergy
and Infectious Disease (NIAID) priority pathogens (1).
Organisms classiﬁed by NIAID as priority pathogens
are selected based on their association as agents or poten-
tial agents of bioterrorism. The priority pathogens
Pathema supports includes ﬁve prokaryotes Bacillus
anthracis, Burkholderia mallei, Burkholderia pseudomallei,
Clostridium botulinum and Clostridium perfringens and one
eukaryote Entamoeba histolytica. To provide researchers
with a comprehensive collection of organisms for compar-
ative analyses, 66 unique strains of priority pathogens are
supported, to include 54 phylogenetically related species.
Organisms are grouped taxonomically by genus, with
associated data stored in four distinct databases, each
accessible through four diﬀerent clade web interfaces.
Each Pathema clade resource, linked from one central
Pathema gateway interface, is tailored to address the
speciﬁc data and analysis needs of each scientiﬁc commu-
nity; feedback gathered through outreach activities.
Pathema disseminates high-quality, up-to-date data to
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curation assertions, and specialty datasets as they relate
to ongoing pathogen and infectious disease research.
The most current data generated is displayed throughout
the resource and Pathema deposits all relevant data
in public repositories such as the Pathogen Portal
(http://www.pathogenportal.org/), GenBank (2) and the
GO repository (3). Integrated with this data is a suite of
sophisticated bioinformatics software and over 50 analysis
tools customized to retrieve, display and compute
results relevant to the research of each Pathema target
pathogen community. Bioinformatics tools for cross-
genome comparisons and identiﬁcation of metabolic
pathways are also integrated to facilitate the identiﬁcation
of potential targets for vaccine development, therapeutics,
and diagnostics. In addition, clade-speciﬁc training
courses, detailed tutorials, standard operating procedures
are oﬀered to provide instruction and documentation on
the use of this system and underlying databases.
PATHEMA ORGANISMS
Pathema supports sequence and detailed curation of six
NIAID target priority pathogens and related species
grouped taxonomically by genus into four clades:
Bacillus, Burkholderia, Clostridium and Entamoeba
(Table 1). These pathogens are included among two of
three high-priority categories (Categories A, B and C)
classiﬁed by NIAID based on their relative capabilities
for causing morbidity or mortality from disease in
case of biowarfare (http://www3.niaid.nih.gov/topics/
BiodefenseRelated/Biodefense/research/CatA.htm). The
inclusion of closely related species provides researchers
with a comprehensive collection of organisms for com-
parative analyses.
The Bacillus clade supports 40 prokaryotic organisms
including the target pathogen B. anthracis (Category A),
as well as the pathogens B. cereus and B. thuringiensis.
Long regarded as one of the preferred biological warfare
agents, B. anthracis is the causative agent of anthrax. Its
potential for use as a bioweapon was demonstrated by the
autumn 2001 anthrax letter attacks in the US. Its lethality,
combined with ease of laboratory production and ability
to disseminate anthrax spores in aerosol form, accounts
for its interest as a biowarfare agent (4).
Included among the 41 prokaryotes supported by the
Burkholderia clade are the target pathogens B. mallei and
B. pseudomallei (Category B), as well as the pathogen
B. cepacia. B. mallei is responsible for glanders, a disease
that occurs mostly in horses and related animals. Glanders
has been associated with war for centuries, to include
the use of B. mallei as a bioweapon in World War I,
World War II, and anecdotal evidence supports its use
in Afghanistan. Its ease of transmission and severity
of disease makes B. mallei of interest as an agent for
bioterrorism (5). Burkholderia pseudomallei, a human
and animal pathogen, is the causative agent of melioidosis,
an infectious disease endemic to Southeast Asia and
northern Australia, and may occur in other tropical
and subtropical regions. Its severe course of infection,
aerosol infectivity and worldwide availability resulted in
its inclusion as a potential agent of biological warfare or
bioterrorism (6).
The Clostridium clade supports 36 prokaryotic
organisms encompassing the four main species responsible
for disease in humans. These include the target pathogens
C. botulinum (Category A), C. perfringens (Category B), as
well as the pathogens C. diﬃcile and C. tetani. Diﬀerent
strains of C. botulinum produce diﬀerent types of toxins
apart from the well-known botulinum neurotoxin, the
causative agent of the disease botulism in humans and
animals (4). The botulism toxin, considered the most
lethal naturally occurring substance, was linked for use
as a bioweapon during World War II and the Persian
Gulf War (7). C. perfringens is known to be the most
widely distributed pathogen in nature. It is shown to be
a causative agent of human diseases such as gas gangrene,
food poisoning, and enteritis necroticans, as well as
various animal diseases (5).
Included in the Entamoeba clade are three parasitic
protists: E. histolytica, E. dispar and E. invadens. The
target pathogen E. histolytica (Category B), is the caus-
ative agent of the most common diarrheal disease,
amebiasis. Amebiasis accounts for between 40000 and
100000 deaths annually, and is predominantly seen in
developing countries where a high prevalence of infection
Table 1. Genomes and organisms supported by Pathema as of 1 August 2009
Pathema clade Target NIAID
pathogen
Organisms
supported
Completed
genomes
Draft
genomes
NIAID
category
Associated
disease
Bacillus 40 21 19
Bacillus anthracis 19 6 13 A Anthrax
Burkholderia 41 24 18
Burkholderia mallei 10 4 6 B Glanders
Burkholderia pseudomallei 12 4 8 B Melioidosis
Clostridium 36 23 13
Clostridium botulinum 15 10 5 A Botulism
Clostridium perfringens 9 3 6 B Enterotoxemia
Entamoeba 33 0
Entamoeba histolytica 1 1 0 B Amebiasis
Total Pathema 120 71 50
A complete list of supported organisms is included in Supplementary Table S1.
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factors that cannot be immediately remedied due to
limited ﬁnancial resources in these countries (8). Its
interest as a potential biothreat organism is its low infec-
tious dose and potential for dissemination through
compromised food and water supplies.
To assist researchers in identifying correlations between
patient phenotype and geography, symptoms/outcome
and pathogen sequence variation, and to gain an under-
standing of the impact of pathogen genomic variations on
drug resistance or vaccine eﬃcacy, Pathema integrates
epidemiological and clinical data. Where available, this
data is obtained from the research community for each
organism and includes: the original source location
of each organism strain, detailed clinical information
(e.g. date isolated, isolation source, historical back-
ground), genotype numbering based on Multi Locus
Sequence Typing (9), and source contact information for
obtaining the DNA.
INTERFACE DESIGN AND DATABASE
DESCRIPTION
The main Pathema gateway interface serves as the central
entry point to access Pathema’s target pathogens and
related species through one of four distinct clade-speciﬁc
web resources: Bacillus, Clostridium, Burkholderia and
Entamoeba. This gateway provides general information,
news and highlights, planned data updates, and tutorials
relevant to the entire Pathema resource, with links to each
of the four clade sites supporting clade-speciﬁc data and
analysis tools. Based on feedback gathered through com-
munity outreach, Pathema’s four clade resources aim to
target the individual research needs of each community by
integrating the speciﬁc datasets and analysis tools
requested by organism experts. Through the customized
development of clade resources, Pathema serves as a core
resource supporting scientiﬁc investigation and hypothesis
generation of its supported target organisms.
The Pathema web interface uses the Coati
(Collaborative Open Applications Tool Initiative) archi-
tecture framework. Coati is an open source project
housed at SourceForge (http://sourceforge.net/projects
/coati-api/). Each clade-speciﬁc web interface interacts
with one of four separate Chado (10) relational database
schemas that house Pathema clade sequence and annota-
tion data, and comparative computes. Chado underlies
many Generic Model Organism Database (GMOD) (11)
installations and is a general schema used to share
genomic data, annotations and analyses.
CURATION DATA TYPES
Pathema generates and continuously updates gene model
and functional annotation data for 120 supported genome
projects, disseminating data of over 600000 predicted
genes with common data types (Table 2). Common data
types are assigned using an automated pipeline to process
the genomic sequences of all Pathema organisms. This
pipeline consists of several algorithms for the prediction
of gene models and genome features (e.g. RNAs, termina-
tors, repeats), and employs a hierarchical evidence ranking
scheme to assign functional annotation [e.g. protein name,
gene symbol, Enzyme Commission (EC) number (12),
Gene Ontology (GO) terms]. By assigning common data
types using one standardized pipeline across all organisms,
comparative analyses become easier and more meaning-
ful to the researcher. Additionally, based on the use of
common data types, a rich set of curation assertions
with supporting evidence are generated. These curation
assertions are based on the Gene Ontology Consortium
and attempt to describe the complete proﬁle (i.e. molecu-
lar function, biological process, cellular location) of
proteins in biologically meaningful ways, those that
cannot be captured by individual data types alone.
Standardized evidence types represent a diverse range of
speciﬁc forms of evidence (i.e. direct assay, mutant
phenotype) used to support each curation assertion. The
use of standardized evidence types facilitates a mechanism
to easily assess the level of conﬁdence supporting each
assertion, ultimately validating hypotheses derived from
the proﬁle analysis of individual proteins, orthologs and
pathway data.
Common annotation data types and curation assertions
with supporting evidence are computationally generated
for all Pathema organisms. With the goal of providing
the scientiﬁc community with the most accurate annota-
tion, automated predictions are manually curated for each
of Pathema’s six target pathogens. Established naming
conventions and evidence interpretation guidelines are
adhered to during this manual process. Additionally, the
genomic annotation of these organisms reﬂects in-depth
manual literature curation of biodefense and infectious
disease related datasets. These datasets include clade-
speciﬁc virulence factors, epitopes (13), protein–protein
interactions (14), multidrug exporters (15) and experimen-
tally characterized proteins. Inclusion of these datasets
enrich existing genome annotation, thereby facilitating
the identiﬁcation of potential new targets of pathogen
research interest.
Although Pathema’s six target pathogens are the
primary focus of manual eﬀort, Pathema strives to
provide the same level of high-quality annotation across
all organisms supported by the Pathema resource.
To achieve this, a homology mapping strategy is
employed. This strategy uses the MUMmer (16) whole
genome alignment program to identify close protein
homologs, with subsequent propagation of high-quality
manually curated data from each target organism to all
closely related Pathema clade members.
All annotation standard operating procedures,
Pathema’s Gene Naming and Annotation Guidelines,
and all other related annotation documentation is obtain-
able throughout the Pathema resource (http://pathema
.jcvi.org/protocols).
GENOME AND COMPARATIVE ANALYSIS TOOLS
Pathema supports over 50 web-based data mining, single
gene, whole-genome and multi-genome comparative tools
D410 Nucleic AcidsResearch, 2010, Vol.38,Database issueto facilitate analyses of genomic sequence and annotation
data across Pathema organisms. Tools are designed to
facilitate scientiﬁc exploration in the areas of functional
curation, pathogenicity, therapeutics, comparative
analysis and functional genomics. While every tool has
several applications, taken together they provide
numerous opportunities for discovery and hypothesis gen-
eration (Supplementary Table S2).
Data mining
Pathema incorporates over 25 diﬀerent search capabilities
that enable data mining and retrieval of all data types
stored in the Pathema database. Search tools query
genes, genomes, sequences or text, matching user-deﬁned
strings across gene loci, gene symbols and protein product
names. Virulence factors, epitopes, experimentally
characterized proteins and protein interaction data can
be retrieved using Pathema search tools across user-
selected organisms. Other queries include EC#,
GenBank, SwissProt (17) and GO id searches, and
common sequence search methods such as BLAST (18),
Hidden Markov Model (19) and protein motif searches
(20) are also available.
Literature mining
A semantic visualization tool, based on the National
Library of Medicine’s SemMed viewer (21), is integrated
within Pathema. This tool provides access to biomedical
literature archived in PubMed, through manually
curated semantic condensate data records of relevant
subjects for each Pathema clade.Records can be displayed
in both graphical and word cloud format, and include
links to external data sites containing relevant informa-
tion, such as genetic databases, Uniﬁed Medical
Language System (UMLS) entries and the original
Medline reference.
Single gene analysis
Individual gene pages highlight annotation data and
associated evidence, as well as provide access to single
gene analysis tools for every gene available on Pathema.
Annotation data displayed and downloadable includes
protein product name, gene symbol, EC#, GO ids, func-
tional role category assignment, and DNA and protein
sequences. Literature references are provided for all
proteins that are identiﬁed virulence factors, are associa-
ted with an epitope(s), interact with another protein(s),
or have experimental characterizations. Calculating
the transmembrane HMM proﬁle (22), secondary struc-
ture and third position GC-Skew are just a few types of
analyses that can be performed. Links to other relevant
resources such as UniProt, GenBank, Prosite, Pfam (23),
etc. are also available.
Whole-genome analysis
Over 20 diﬀerent displays and analyses of whole-genome
data are included in Pathema. These analysis tools enable
the display and analysis of individual genomic data using
a variety of diﬀerent methods. Whole-genome data can
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Nucleic Acids Research, 2010,Vol.38, Database issue D411be displayed graphically as a linear representation of genes
on regions of a chromosome or as a complete circle for an
entire chromosome. Data can be investigated through bio-
chemical pathways (24–26), codon usage tables, percent
GC plots, computer generated 2D and restriction digest
gels, and summary information such as average gene size
or numbers of coding regions can be retrieved as viewable
and downloadable tables and lists.
Comparative analysis
Integrated into Pathema are over 15 diﬀerent compara-
tive analysis tools for multi-genome comparisons
among Pathema clade organisms (Figure 1). The basis
for Pathema’s current comparative tools is either
pre-generated Jaccard orthologous protein clusters or
All versus All blastp searches. Incorporated, are the
most popular tools of the publicly available Sybil compar-
ative analysis suite (27). Sybil uses Pathema’s pre-
generated protein clusters as the underlying data for its
synteny gradient and comparative genomic displays.
Sybil protein cluster ortholog, paralog and singleton
data are also available.
COMMUNITY OUTREACH
Pathema launched a community outreach strategic plan to
assess the scientiﬁc and informatic needs of the pathogen
research community. This community consists of over 950
identiﬁed researchers who study the six Pathema target
pathogens, with over 25% participating in Pathema com-
munity outreach eﬀorts. These eﬀorts were designed to
gather feedback during the initial phases of resource devel-
opment and testing, with feedback continuously gathered
during various training and other outreach activities.
Pathema provides detailed training in the form of clade-
speciﬁc annotation jamborees and hands-on Pathema
resource workshops conducted both on site and in
conjunction with major organism speciﬁc conferences.
In-depth resource tutorials and manuals that describe
Pathema tools and data are also available. Currently 20
Figure 1. Pathema-Burkholderia Comparative Tools. This ﬁgure shows some of the comparative tools available on Pathema for the Burkholderia
clade. (A) Protein orthologous cluster: Burkholderia multidrug eﬄux pump AmrA region and Clustal alignments; (B) Comparative genomic
region: Burkholderia whole genomes aligned to a reference; (C) Evidence comparison: diﬀerences in evidence occurrence across multiple
Burkholderia genomes and phylogeny of selected proteins.
D412 Nucleic AcidsResearch, 2010, Vol.38,Database issuescientiﬁc publications reference the use of Pathema and its
underlying data sets (28–46).
AVAILABILITY
Pathema is maintained at the J. Craig Venter Institute
and can be accessible through a web browser at
http://pathema.jcvi.org. There are no license restrictions
for user access to any of the data supported by
Pathema, and all source code is managed under an
open-source collaborative development paradigm. Web
scripts and data maintenance programs are located
at SourceForge under the Pathema project (http://
sourceforge.net/projects/pathema). Pathema sequence
and annotation data formatted GFF3 ﬁles can be
obtained from the Pathema FTP download site
(ftp://ftp.pathogenportal.org/gﬀ3/Pathema/); retrievable
from the ‘downloads’ tab oﬀ the main resource
header or linked directly from each organism
homepage. Additionally results obtained from complex
searches or genomic comparisons are available in tab-
delimited format throughout Pathema on each respective
results page.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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